Sophie Verreydt SRL
0.5 FTESophie Verreydt reported total assets of 661,590 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Jul 2026), with 0.5 full-time equivalent.
The score of Sophie Verreydt shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sophie Verreydt's annual accounts
| 2025 | |
|---|---|
| Net result | 99,023 € |
| Equity | 129,023 € |
| Cash | 121,719 € |
| EBITDA | 163,648 € |
| Total assets | 661,590 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
Sophie Verreydt's financial analysis
- Solvency19.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sophie Verreydt
Sophie Verreydt's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1017.375.986
- VAT number
- BE1017375986
- Peppol
- Registered · 0208:1017375986 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 13 Dec 2024
- Registered office
- 9160 Lokeren
- Size
- Micro · 0.5 FTE
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sophie Verreydt (SRL) has been based in Lokeren since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 99,023 € and equity of 129,023 €; its revenue is not published. With 0.5 full-time equivalents, it is a micro-enterprise by headcount.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sophie Verreydt
Companies in the same business, of comparable size and area, outside its group.
- T.Lamote Retail sale of pharmaceutical products Merchtem · balance sheet 663,074 €
- Pharmacie de Cherain Retail sale of pharmaceutical products Gouvy · balance sheet 658,226 €
- Van de Weyer Apotheek Retail sale of pharmaceutical products Landen · balance sheet 661,590 €
- Henrion-Fourez Retail sale of pharmaceutical products Brunehaut · balance sheet 661,950 €
- Apotheek Debremaeker Retail sale of pharmaceutical products Halle · balance sheet 661,199 €
- Ibti Pharma Retail sale of pharmaceutical products Mons · balance sheet 660,797 €
- Corums Retail sale of pharmaceutical products Halle · balance sheet 662,462 €
- Natural Pharma Retail sale of pharmaceutical products Brussels · balance sheet 662,921 €
Frequently asked questions about Sophie Verreydt
What is the revenue of Sophie Verreydt?
Sophie Verreydt files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sophie Verreydt?
In Belgium, the VAT number is the company number prefixed with BE: BE1017375986 for Sophie Verreydt, if the company is VAT-registered. Its company number (CBE) is 1017.375.986.
Where is the registered office of Sophie Verreydt?
According to the CBE register, the registered office of Sophie Verreydt is in 9160 Lokeren.
What is the equity of Sophie Verreydt?
At the close of the 2025 financial year, the equity of Sophie Verreydt amounts to 129,023 €, a solvency of 19.5% of total assets.
How many people work at Sophie Verreydt?
0.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Sophie Verreydt?
The register lists 1 active mandates at Sophie Verreydt. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sophie Verreydt
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →